IRMD
Price
$60.50
Change
+$0.14 (+0.23%)
Updated
Jun 6 closing price
Capitalization
557.04M
54 days until earnings call
PLSE
Price
$17.10
Change
+$0.78 (+4.78%)
Updated
Jun 6 closing price
Capitalization
481.01M
60 days until earnings call
Interact to see
Advertisement

IRMD vs PLSE

Header iconIRMD vs PLSE Comparison
Open Charts IRMD vs PLSEBanner chart's image
iRadimed
Price$60.50
Change+$0.14 (+0.23%)
Volume$29.71K
Capitalization557.04M
Pulse Biosciences
Price$17.10
Change+$0.78 (+4.78%)
Volume$158.35K
Capitalization481.01M
IRMD vs PLSE Comparison Chart
Loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRMD vs. PLSE commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a Buy and PLSE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (IRMD: $60.50 vs. PLSE: $17.10)
Brand notoriety: IRMD and PLSE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRMD: 80% vs. PLSE: 98%
Market capitalization -- IRMD: $557.04M vs. PLSE: $481.01M
IRMD [@Medical Specialties] is valued at $557.04M. PLSE’s [@Medical Specialties] market capitalization is $481.01M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 3 FA rating(s) are green whilePLSE’s FA Score has 0 green FA rating(s).

  • IRMD’s FA Score: 3 green, 2 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, IRMD is a better buy in the long-term than PLSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 7 TA indicator(s) are bullish while PLSE’s TA Score has 4 bullish TA indicator(s).

  • IRMD’s TA Score: 7 bullish, 4 bearish.
  • PLSE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than PLSE.

Price Growth

IRMD (@Medical Specialties) experienced а +4.53% price change this week, while PLSE (@Medical Specialties) price change was -1.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.46%. For the same industry, the average monthly price growth was +5.98%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

IRMD is expected to report earnings on Jul 31, 2025.

PLSE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+2.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRMD($557M) has a higher market cap than PLSE($481M). IRMD YTD gains are higher at: 10.681 vs. PLSE (-1.781). IRMD has higher annual earnings (EBITDA): 20.8M vs. PLSE (-42.37M). IRMD has more cash in the bank: 49.8M vs. PLSE (44.4M). IRMD has less debt than PLSE: IRMD (2.04M) vs PLSE (9.14M). IRMD has higher revenues than PLSE: IRMD (65.6M) vs PLSE (0).
IRMDPLSEIRMD / PLSE
Capitalization557M481M116%
EBITDA20.8M-42.37M-49%
Gain YTD10.681-1.781-600%
P/E Ratio31.84N/A-
Revenue65.6M0-
Total Cash49.8M44.4M112%
Total Debt2.04M9.14M22%
FUNDAMENTALS RATINGS
IRMD vs PLSE: Fundamental Ratings
IRMD
PLSE
OUTLOOK RATING
1..100
7515
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
2488
SMR RATING
1..100
4095
PRICE GROWTH RATING
1..100
4059
P/E GROWTH RATING
1..100
22100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (17) in the Medical Specialties industry is somewhat better than the same rating for PLSE (58). This means that IRMD’s stock grew somewhat faster than PLSE’s over the last 12 months.

IRMD's Profit vs Risk Rating (24) in the Medical Specialties industry is somewhat better than the same rating for PLSE (88). This means that IRMD’s stock grew somewhat faster than PLSE’s over the last 12 months.

IRMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for PLSE (95). This means that IRMD’s stock grew somewhat faster than PLSE’s over the last 12 months.

IRMD's Price Growth Rating (40) in the Medical Specialties industry is in the same range as PLSE (59). This means that IRMD’s stock grew similarly to PLSE’s over the last 12 months.

IRMD's P/E Growth Rating (22) in the Medical Specialties industry is significantly better than the same rating for PLSE (100). This means that IRMD’s stock grew significantly faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRMDPLSE
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
58%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IASTX23.490.02
+0.09%
Macquarie Asset Strategy Fund Cl R6
SBSPX46.03N/A
N/A
Franklin S&P 500 Index A
RYKIX102.04N/A
N/A
Rydex Banking Inv
FDGFX39.51N/A
N/A
Fidelity Dividend Growth
RSIFX26.94N/A
N/A
Victory RS Science and Technology A

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with HBIO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then HBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+0.23%
HBIO - IRMD
55%
Loosely correlated
-0.99%
ITGR - IRMD
45%
Loosely correlated
+0.36%
VREX - IRMD
44%
Loosely correlated
+0.60%
ICUI - IRMD
44%
Loosely correlated
+0.11%
TWST - IRMD
44%
Loosely correlated
+4.09%
More

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+4.78%
CERS - PLSE
39%
Loosely correlated
+9.42%
IRMD - PLSE
33%
Loosely correlated
+0.23%
STXS - PLSE
31%
Poorly correlated
+0.45%
ARAY - PLSE
29%
Poorly correlated
-15.13%
SIBN - PLSE
28%
Poorly correlated
-0.84%
More